Biotech News
Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Nov. 12, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value healthcare company, today announced financial results and business highlights for the fourth quarter and full year fiscal 2026 ended September 30, 2026.
